Literature DB >> 20615567

Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: Results of a multicenter, large-scale study.

Giada Sebastiani1, Diego Tempesta, Giovanna Fattovich, Laurent Castera, Philippe Halfon, Marc Bourliere, Franco Noventa, Paolo Angeli, Alfredo Saggioro, Alfredo Alberti.   

Abstract

BACKGROUND & AIMS: Preliminary data suggest that non-invasive methods could be useful to assess presence of oesophageal varices (OV) in cirrhotic patients. We aimed to further investigate simple serum non-invasive markers for diagnosing and grading OV.
METHODS: A retrospective set of 510 cirrhotics and a prospective set of 110 cirrhotics were enrolled consecutively in five centers. Platelets, AST-to-ALT ratio, AST-to-platelet-ratio index, Forns' index, Lok index, Fib-4, and Fibroindex were measured within 2 months from upper endoscopy, taken as a gold standard. Performance was expressed as sensitivity, specificity, positive, and negative predictive values (PPV, NPV), accuracy, and area under the curve (AUC).
RESULTS: A combination of Lok index (cutoff=1.5) and Forns' index (cutoff=8.8) had 0.80 AUC (0.76-0.84, 95% CI), and high NPV (>90%) to exclude clinically relevant OV, defined as large OV or small OV with red signs or in Child-Pugh C cirrhosis. By applying this combination, upper endoscopy would have been avoided in 1/3 of our cirrhotics. Large OV could be excluded with 96% NPV by Lok index (cutoff=1.5). A combination of Lok index (cutoff=0.9) and Forns' index (cutoff=8.5) predicted presence of any grade OV with good performance: 0.82 AUC (0.76-0.88, 95% CI), 88% PPV.
CONCLUSIONS: Serum non-invasive markers may be useful as a first line tool to identify cirrhotic patients in which the risk of clinically relevant OV is trivial, and to reduce the number of upper endoscopies. However, we are still far from the possibility of replacing upper endoscopy by simple serum non-invasive markers in the vast majority of patients.
Copyright © 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20615567     DOI: 10.1016/j.jhep.2010.04.019

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  39 in total

Review 1.  Performance of platelet count/spleen diameter ratio for diagnosis of esophageal varices in cirrhosis: a meta-analysis.

Authors:  Li Ying; Xiao Lin; Zuo-Liu Xie; Yuan-Ping Hu; Ke-Qing Shi
Journal:  Dig Dis Sci       Date:  2012-02-26       Impact factor: 3.199

2.  Clinical role of non-invasive assessment of portal hypertension.

Authors:  Massimo Bolognesi; Marco Di Pascoli; David Sacerdoti
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

Review 3.  Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.

Authors:  Agostino Colli; Juan Cristóbal Gana; Jason Yap; Thomasin Adams-Webber; Natalie Rashkovan; Simon C Ling; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2017-04-26

4.  Role of non-invasive markers in prediction of esophageal varices and variceal bleeding in patients of alcoholic liver cirrhosis from central India.

Authors:  Harit Goverdhan Kothari; Sudhir Jagdishoprasad Gupta; Nitin Rangrao Gaikwad; Tushar Hiralal Sankalecha; Amol Rajendra Samarth
Journal:  Turk J Gastroenterol       Date:  2019-12       Impact factor: 1.852

Review 5.  Invasive and non-invasive assessment of portal hypertension.

Authors:  Jonathan Chung-Fai Leung; Thomson Chi-Wang Loong; James Pang; Jeremy Lok Wei; Vincent Wai-Sun Wong
Journal:  Hepatol Int       Date:  2017-03-30       Impact factor: 6.047

6.  Liver stiffness measurement by acoustic radiation force impulse is useful in predicting the presence of esophageal varices or high-risk esophageal varices among patients with HCV-related cirrhosis.

Authors:  Naoki Morishita; Naoki Hiramatsu; Tsugiko Oze; Naoki Harada; Ryoko Yamada; Masanori Miyazaki; Takayuki Yakushijin; Takuya Miyagi; Yuichi Yoshida; Tomohide Tatsumi; Tatsuya Kanto; Tetsuo Takehara
Journal:  J Gastroenterol       Date:  2013-09-05       Impact factor: 7.527

7.  Noninvasive Assessment of Fibrosis Regression in Hepatitis C Virus Sustained Virologic Responders.

Authors:  Hirsh D Trivedi; Steven C Lin; Daryl T Y Lau
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-10

Review 8.  Noninvasive assessment of portal hypertension in cirrhosis: liver stiffness and beyond.

Authors:  Horia Stefanescu; Bogdan Procopet
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 9.  Chronic hepatitis C and liver fibrosis.

Authors:  Giada Sebastiani; Konstantinos Gkouvatsos; Kostas Pantopoulos
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

10.  Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms.

Authors:  Giada Sebastiani
Journal:  World J Gastroenterol       Date:  2009-05-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.